Claims
- 1. An assembly for treating a body vessel, comprising:a radially expandable stent, having an inner surface and an outer surface; and a tubular liner consisting of expanded polytetrafluoroethylene, having a microstructure characterized by nodes interconnected by fibrils, wherein the liner is positioned along a length of the stent, covering at least one of the inner and outer surfaces; wherein the assembly is permanently radially expandable in vivo from a first diameter to a larger second diameter, and wherein the tubular liner maintains structural integrity at the second diameter up to approximately 100% of the first diameter.
- 2. The assembly according to claim 1, wherein said tubular liner has a radial expansion coefficient of less than 2.0.
- 3. The assembly according to claim 1, wherein said tubular liner has a radial expansion coefficient of less than 1.7.
- 4. The assembly according to claim 1, wherein said tubular liner has a radial expansion coefficient of less than 1.5.
- 5. The assembly according to claim 1, wherein said tubular liner has a radial expansion coefficient of less than 1.0.
- 6. The assembly according to claim 1, wherein said tubular liner has a radial expansion coefficient of less than 30.
- 7. The assembly according to claim 1, wherein said tubular liner has a radial expansion coefficient of less than 2.
- 8. The assembly according to claim 1, wherein said tubular liner has a radial expansion coefficient of less than 10.
- 9. The assembly according to claim 1, wherein said tubular liner has a radial expansion coefficient of less than 5.
- 10. The assembly according to claim 1, wherein said tubular liner has a reduction ratio to lubricant level of about 5 or less.
- 11. The assembly according to claim 10, wherein said lubricant level is between 16 and 35%.
- 12. The assembly according to claim 10, wherein said lubricant level is between 16 and 35%.
- 13. The assembly according to claim 10, wherein said reduction ratio is less than 300:1.
- 14. The assembly according to claim 10, wherein said reduction ratio is less than 200:1.
- 15. The assembly according to claim 10, wherein said reduction ratio is less than 125:1.
Parent Case Info
This is a continuation of application Ser. No. 08/588,228 filed Jan. 18, 1996, now abandoned; which is a continuation application of Ser. No. 08/239,239, filed on May 6, 1994 (abandoned).
US Referenced Citations (51)
Foreign Referenced Citations (20)
Number |
Date |
Country |
3918736 |
Dec 1990 |
DE |
0 221 570 |
May 1987 |
EP |
0 232 543 |
Aug 1987 |
EP |
0 267 719 |
May 1988 |
EP |
0 269 449 |
Jun 1988 |
EP |
0 335 341 |
Oct 1989 |
EP |
0 461 791 |
Dec 1991 |
EP |
0 551 179 |
Jul 1993 |
EP |
1 506 432 |
Apr 1978 |
GB |
61-17648 |
Apr 1955 |
JP |
58-44378 |
Feb 1979 |
JP |
6-1143 |
Apr 1980 |
JP |
62-152467 |
Jul 1987 |
JP |
2-69220 |
Mar 1990 |
JP |
WO 9107203 |
May 1991 |
WO |
WO 9113648 |
Sep 1991 |
WO |
WO 9317636 |
Sep 1993 |
WO |
WO 9401056 |
Jan 1994 |
WO |
WO 9412136 |
Jun 1994 |
WO |
WO 9413224 |
Jun 1994 |
WO |
Non-Patent Literature Citations (3)
Entry |
Julio C. Palmaz, “Uses of balloon expandable stents in combination with PTFE”, W.B. Saunders Company, Ltd., pp. 36-42, 1994. |
U.S. Ser. No. 08/135,226, Andersen et al., “Medical Stents for Body Lumens Exhibiting Peristaltic Motion” Oct. 13, 1993. |
U.S. Ser. No. 07/960,584, Andersen et al., “Medical Stents for Body Lumens Exhibiting Peristaltic Motion” Oct. 13, 1992. |
Continuations (2)
|
Number |
Date |
Country |
Parent |
08/588228 |
Jan 1996 |
US |
Child |
08/773281 |
|
US |
Parent |
08/239239 |
May 1994 |
US |
Child |
08/588228 |
|
US |